bf/NASDAQ:HRTX_icon.jpeg

COM:HERONTX

Heron Therapeutics

  • Stock

Last Close

1.06

22/11 21:00

Market Cap

162.74M

Beta: -

Volume Today

1.34M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.28M
-
30.77M
2,305.55%
77.47M
151.81%
145.97M
88.41%
88.64M
39.28%
86.35M
2.59%
107.67M
24.70%
127.04M
17.99%
cost of revenue
35K
-
4.59M
13,008.57%
27.51M
499.65%
61.62M
123.97%
36.19M
41.27%
46.02M
27.17%
54.87M
19.24%
65.11M
18.64%
gross profit
1.24M
-
26.18M
2,004.42%
49.96M
90.85%
84.35M
68.83%
52.45M
37.82%
40.33M
23.12%
52.80M
30.93%
61.94M
17.31%
selling and marketing expenses
47.67M
-
56.60M
18.74%
64.60M
14.14%
89.76M
38.94%
63.85M
28.87%
87.18M
36.53%
82.51M
5.35%
67.64M
18.02%
general and administrative expenses
21.68M
-
19.73M
8.99%
35.74M
81.17%
21.37M
40.22%
25.55M
19.60%
29.26M
14.51%
37.90M
29.50%
42.23M
11.42%
40.15M
4.91%
37.44M
6.76%
49.01M
30.92%
selling general and administrative expenses
21.68M
-
19.73M
8.99%
35.74M
81.17%
69.03M
93.15%
82.16M
19.01%
93.87M
14.26%
127.66M
36.00%
106.08M
16.91%
127.33M
20.04%
119.95M
5.80%
116.66M
2.75%
research and development expenses
32.78M
-
54.83M
67.28%
61.18M
11.58%
103.13M
68.55%
138.58M
34.38%
140.03M
1.05%
167.38M
19.53%
174.53M
4.27%
130.82M
25.05%
107.51M
17.82%
55.90M
48.01%
other expenses
-1.81M
-
-666K
63.12%
-2.23M
234.53%
-38K
98.29%
5.10M
13,513.16%
5.95M
16.64%
885K
85.11%
-2.85M
422.60%
-7.37M
158.00%
560K
107.60%
cost and expenses
54.46M
-
74.56M
36.92%
96.92M
29.99%
172.19M
77.66%
225.32M
30.86%
261.41M
16.02%
356.66M
36.44%
316.80M
11.18%
304.17M
3.99%
282.33M
7.18%
237.66M
15.82%
operating expenses
54.46M
-
74.56M
36.92%
96.92M
29.99%
172.16M
77.62%
220.74M
28.22%
233.90M
5.96%
295.04M
26.14%
280.61M
4.89%
258.15M
8.00%
227.46M
11.89%
172.55M
24.14%
interest expense
826K
-
887K
7.38%
958K
8.00%
2.66M
178.08%
3.94M
47.79%
2.67M
32.13%
1.47M
44.91%
1.90M
29.14%
2.41M
26.78%
2.47M
2.66%
3.87M
56.35%
ebitda
-54.46M
-
-74.56M
36.92%
-96.92M
29.99%
-170.91M
76.34%
-192.02M
12.35%
-183.94M
4.21%
-208.65M
13.44%
-228.16M
9.35%
-217.83M
4.53%
-174.66M
19.82%
-107.72M
38.33%
operating income
-54.46M
-
-74.56M
36.92%
-96.92M
29.99%
-170.91M
76.34%
-194.56M
13.83%
-183.94M
5.46%
-210.69M
14.55%
-228.16M
8.29%
-217.83M
4.53%
-174.66M
19.82%
-110.61M
36.67%
depreciation and amortization
333K
-
578K
73.57%
734K
26.99%
1.10M
49.73%
1.53M
39.31%
1.51M
1.18%
2.04M
35.10%
2.85M
39.29%
3.02M
6.11%
2.89M
4.37%
2.90M
0.35%
total other income expenses net
-826K
-
-1.81M
118.64%
-666K
63.12%
-2.23M
234.53%
-38K
98.29%
5.10M
13,513.16%
5.95M
16.64%
885K
85.11%
-2.85M
422.60%
-7.37M
158.00%
56K
100.76%
income before tax
-55.28M
-
-76.37M
38.14%
-97.59M
27.79%
-173.14M
77.42%
-197.48M
14.06%
-178.84M
9.44%
-204.75M
14.49%
-227.28M
11.00%
-220.68M
2.90%
-182.02M
17.52%
-110.56M
39.26%
income tax expense
-333K
-
-578K
73.57%
-734K
26.99%
-1.10M
49.73%
3.90M
454.78%
7.77M
99.26%
-2.85M
-
-3.02M
6.11%
-47.51M
1,472.59%
net income
-55.28M
-
-76.37M
38.14%
-97.59M
27.79%
-173.14M
77.42%
-197.48M
14.06%
-178.84M
9.44%
-204.75M
14.49%
-224.43M
9.61%
-217.66M
3.02%
-134.52M
38.20%
-110.56M
17.81%
weighted average shs out
16.16M
-
26.57M
64.38%
33.08M
24.51%
37.92M
14.64%
54.04M
42.49%
73.19M
35.44%
81.78M
11.73%
90.77M
11.00%
98.47M
8.48%
108.88M
10.57%
138.13M
26.87%
weighted average shs out dil
16.16M
-
26.57M
64.38%
33.08M
24.51%
37.92M
14.64%
54.04M
42.49%
73.19M
35.44%
81.78M
11.73%
90.77M
11.00%
98.47M
8.48%
108.88M
10.57%
138.13M
26.87%
eps
-3.42
-
-2.87
16.08%
-2.95
2.79%
-4.57
54.92%
-3.65
20.13%
-2.44
33.15%
-2.50
2.46%
-2.47
1.20%
-2.21
10.53%
-1.24
43.89%
-0.80
35.48%
epsdiluted
-3.42
-
-2.87
16.08%
-2.95
2.79%
-4.57
54.92%
-3.65
20.13%
-2.44
33.15%
-2.50
2.46%
-2.47
1.20%
-2.21
10.53%
-1.24
43.89%
-0.80
35.48%

All numbers in (except ratios and percentages)